Apple's Supply Squeeze Could Last Into 2027-Why UBS Trimmed the Multiple, Not the Rating

Apple's strong demand is still colliding with a tighter supply chain

This is the setup UBS highlighted after Apple's management warned that a tighter supply backdrop could last into fiscal 2027. Even when demand is healthy, investors still care about what actually ships. If Apple cannot meet that demand, revenue can stay on the table and margins can come under pressure.

Why the warning matters now

UBS was reacting to fresh management commentary, not an old thesis. Tim Cook said the September quarter should see a much bigger impact on revenue from supply constraints, with less flexibility in the supply chain and tighter availability of the advanced nodes Apple uses. The question is no longer whether Apple had one soft quarter. It is whether this becomes a longer stretch of slower growth and lower profitability.

The bull case and the near-term bear case

The bull case is straightforward: part of this squeeze is coming from demand stronger than expected, especially for iPhone and Mac. That suggests the product cycle still has real pull.

The near-term bear case is cleaner. Apple said it expects even higher memory costs in the September quarter, and UBS warned that higher memory costs and increasing component expenses could pressure profitability. Shares fell nearly 10% after earnings, which shows investors are ready to react quickly when supply and cost risk threaten the next few quarters. The issue is not Apple's overall health. It is whether the squeeze can still weigh on the stock before it eases.

Two forces can stretch the problem beyond one quarter

When demand runs hotter than expected and memory stays tight, Apple cannot rely on the same buffers quarter after quarter. Over time, inventory advantages fade and cost pressure becomes harder to absorb.

Capacity is harder to expand than forecasts

Cook described the problem less as a supplier break and more as a demand-forecast mismatch. The product cycle was stronger than modeled, and that put added pressure on factories, chips, and memory allocations. Apple is also dealing with an issue with the availability of the advanced nodes its chips are produced on. That is one reason investors should be cautious about treating this as a single-quarter disruption.

Memory costs are rising across the industry

There is also a broader cost issue underneath Apple's supply strain. Apple said memory expenses increased in the March quarter, rose again significantly in June, and are expected to increase further in September. UBS echoed that read, warning that higher memory costs and increasing component expenses could weigh on profitability. In practical terms, the inventory cushion Apple could lean on is helping less over time.

Why UBS trimmed the multiple, not the rating

Apple still delivered very strong hardware demand. The company reported iPhone and Mac sales performing better than expected, growing 22% and 29% respectively year over year. But strong demand does not fully offset a tighter component market. If Apple has to secure more memory at higher prices, each extra dollar of revenue can carry a heavier cost burden.

UBS did not downgrade the business. It kept a cautious stance on valuation heading into fiscal 2027, reflecting margin pressure and supply chain strain rather than a collapse in demand.

What keeps Apple at Neutral: valuation, mixed quarter details, and persistent supply risk

UBS maintained a $296 price target and a Neutral rating. That reads less like a verdict on Apple's long-term quality and more like a call on the stock's setup if supply constraints keep pressuring margins.

What the quarter actually showed

iPhone revenue came in at $54.3 billion versus UBS's $53.3 billion estimate, which supports the view that the core device franchise remains strong. Services revenue, though, was $30.7 billion versus UBS's $31.4 billion forecast. Combined with the stock's roughly 15% gain in July, that leaves less room for error if the next supply test runs longer than expected.

Why Neutral still fits if the squeeze persists

Management said supply constraints could have a much bigger impact on revenue during the September quarter across iPhone, iPad, and Mac. If that coincides with higher memory and component costs, strong demand alone may not justify the same valuation multiple. And if supply concerns last into fiscal 2027, investors may not get a clean rerating window anytime soon.

What to watch next

Positive signals - Apple shows the September-quarter revenue impact is manageable through the autumn launch. - Supply constraints stop worsening sequentially instead of increasing significantly sequentially. - Services recovers after missing UBS's latest forecast.

Risk signals - Supply issues keep spreading across iPhone, iPad, and Mac. - Advanced-node availability remains tight, as Cook flagged on the earnings call. - The market keeps framing Apple around a more challenging margin outlook heading into fiscal 2027 rather than around durable demand quality.

What would change the view - The September launch clears, supply pressure fades, and margin concerns ease enough to make the cautious outlook less relevant. - Services reaccelerates and strong demand starts to outweigh the component-cost headwind.

That is the practical meaning of UBS's Neutral: not a dismissal of Apple, but a wait-and-see stance while supply and cost risk remain unresolved.